Roderick Wong - Net Worth and Insider Trading
Roderick Wong Net Worth
The estimated net worth of Roderick Wong is at least $63 Million dollars as of 2024-05-04. Roderick Wong is the CEO, 10% Owner of Health Sciences Acquisitions Corp 2 and owns about 2,808,512 shares of Health Sciences Acquisitions Corp 2 (HSAQ) stock worth over $37 Million. Roderick Wong is also the CEO of Immunovant Inc and owns about 902,498 shares of Immunovant Inc (IMVT) stock worth over $26 Million. Details can be seen in Roderick Wong's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Roderick Wong has not made any transactions after 2023-01-24 and currently still holds the listed stock(s).
Transaction Summary of Roderick Wong
Roderick Wong Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Roderick Wong owns 17 companies in total, including Athira Pharma Inc (ATHA) , DermTech Inc (CNACU) , and Health Sciences Acquisitions Corp 2 (HSAQ) among others .
Click here to see the complete history of Roderick Wong’s form 4 insider trades.
Insider Ownership Summary of Roderick Wong
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATHA | Athira Pharma Inc | 2020-09-17 | 10 percent owner |
| CNACU | DermTech Inc | 2020-08-17 | 10 percent owner |
| HSAQ | Health Sciences Acquisitions Corp 2 | 2023-01-24 | director & 10 percent owner & Chief Executive Officer |
 | | 2022-09-07 | 10 percent owner |
| | 2018-01-04 | director & 10 percent owner |
| | 2020-06-11 | director & 10 percent owner |
| | 2019-12-11 | 10 percent owner |
| | 2019-12-11 | director & Chief Executive Officer |
| | 2019-06-18 | 10 percent owner |
| | 2020-10-16 | 10 percent owner |
| | 2019-08-29 | 10 percent owner |
| | 2021-03-11 | 10 percent owner |
| | 2019-12-11 | director & Chief Executive Officer |
| | 2022-09-23 | 10 percent owner |
| | 2021-11-04 | 10 percent owner |
| | 2021-11-04 | 10 percent owner |
| | 2023-01-24 | director & 10 percent owner & Chief Executive Officer |
Roderick Wong Latest Holdings Summary
Roderick Wong currently owns a total of 2 stocks. Among these stocks, Roderick Wong owns 2,808,512 shares of Health Sciences Acquisitions Corp 2 (HSAQ) as of January 24, 2023, with a value of $37 Million and a weighting of 58.94%. Roderick Wong also owns 902,498 shares of Immunovant Inc (IMVT) as of December 11, 2019, with a value of $26 Million and a weighting of 41.06%.
Latest Holdings of Roderick Wong
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HSAQ | Health Sciences Acquisitions Corp 2 | 2023-01-24 | 2,808,512 | 13.31 | 37,381,295 |
| IMVT | Immunovant Inc | 2019-12-11 | 902,498 | 28.86 | 26,046,092 |
Holding Weightings of Roderick Wong
Roderick Wong Form 4 Trading Tracker
According to the SEC Form 4 filings, Roderick Wong has made a total of 2 transactions in Health Sciences Acquisitions Corp 2 (HSAQ) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Health Sciences Acquisitions Corp 2 is the acquisition of 1,808,512 shares on January 24, 2023, which cost Roderick Wong around $18 Million.
According to the SEC Form 4 filings, Roderick Wong has made a total of 12 transactions in Immunovant Inc (IMVT) over the past 5 years, including 12 buys and 0 sells. The most-recent trade in Immunovant Inc is the acquisition of 31,500 shares on December 11, 2019, which cost Roderick Wong around $343,980.
Insider Trading History of Roderick Wong
- 1
Roderick Wong Trading Performance
GuruFocus tracks the stock performance after each of Roderick Wong's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Roderick Wong is 49.52%. GuruFocus also compares Roderick Wong's trading performance to market benchmark return within the same time period. The performance of stocks bought by Roderick Wong within 3 months outperforms 13 times out of 13 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Roderick Wong's insider trading performs compared to the benchmark.
Performance of Roderick Wong
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 43.64 | | | | | |
| Relative Return to S&P 500(%) | 40.22 | | | | | |
Roderick Wong Ownership Network
Roderick Wong Owned Company Details
What does Athira Pharma Inc do?
Who are the key executives at Athira Pharma Inc?
Roderick Wong is the 10 percent owner of Athira Pharma Inc. Other key executives at Athira Pharma Inc include See Below Andrew Gengos , Chief Operating Officer Mark James Litton , and Vice President of Discovery Kevin Church .
Athira Pharma Inc (ATHA) Insider Trades Summary
Over the past 18 months, Roderick Wong made no insider transaction in Athira Pharma Inc (ATHA). Other recent insider transactions involving Athira Pharma Inc (ATHA) include a net purchase of 77,596 shares made by Andrew Gengos , a net sale of 9,640 shares made by Mark James Litton , and a net sale of 4,824 shares made by Kevin Church .
In summary, during the past 3 months, insiders sold 0 shares of Athira Pharma Inc (ATHA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 26,528 shares of Athira Pharma Inc (ATHA) were sold and 800,698 shares were bought by its insiders, resulting in a net purchase of 774,170 shares.
Athira Pharma Inc (ATHA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Athira Pharma Inc Insider Transactions
Roderick Wong Mailing Address
Above is the net worth, insider trading, and ownership report for Roderick Wong. You might contact Roderick Wong via mailing address: C/o Rtw Investments, Lp, 40 10th Avenue, 7th Floor, New York Ny 10014.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
